Results 21 to 30 of about 122 (68)

Expression analysis and mapping of Viral—Host Protein interactions of Poxviridae suggests a lead candidate molecule targeting Mpox [PDF]

open access: gold
Tamizhini Loganathan   +8 more
openalex   +1 more source

Development of the drug oncolytic immunotherapy based on vaccinia viruses <i>(Vaccinia virus, Orthopoxvirus, Chordopoxvirinae, Poxviridae)</i> against breast cancer

open access: diamond, 2020
Т. В. Бауэр   +5 more
openalex   +2 more sources

Computational Vaccine Design for Poxviridae Family Viruses

open access: closed, 2023
The computational approach to designing vaccines has several useful characteristics over traditional vaccine development, such as being highly specific, less time-consuming and less expensive. Thus, this chapter describes an immunoinformatics workflow to design a vaccine against a member of the Poxviridae family known as Monkeypox virus.
Abbas Khan   +2 more
openalex   +3 more sources

Development of Methodology Based on Commercialized SERS-Active Substrates for Rapid Discrimination of Poxviridae Virions

open access: closedAnalytical Chemistry, 2008
Surface-enhanced Raman spectroscopy (SERS) can be made an attractive approach for identification of Raman-active compounds and biological materials (i.e., toxins, viruses, or intact bacterial cells/spores) through development of reproducible, spatially uniform SERS-active substrates.
Troy A. Alexander
openalex   +4 more sources

Poxviridae Pneumonia

open access: closed
Poxviridae family includes several viruses that infecting humans usually causes skin lesions only, but in some cases their clinical course is complicated by viral pneumonia (with or without bacterial superinfections). Historically variola virus has been the poxviridae most frequently associated with the development of pneumonia with many large ...
Francesco Nucera   +6 more
openalex   +5 more sources

Poxviridae

open access: closed, 2022
Brett W. Petersen
  +4 more sources

Poxviridae

open access: closed, 2012
Zack Moore
openalex   +2 more sources

Home - About - Disclaimer - Privacy